Multiple securities class action lawsuits filed: Can Hims & Hers stock avoid deeper losses?

Traders Union
All News
Stocks
Hims & Hers slips 0.31% today

Highlights

Securities class action lawsuits allege Hims & Hers failed to disclose consumer data sharing, premature prescription charges, and potentially unlawful enrollment practices.
These cases increase regulatory scrutiny and financial liability risk, raising uncertainty around the company’s operations and cash flows.
HIMS stock trades below short- and medium-term moving averages with bearish momentum, projected between $27.14 to $30.26, with a 79% probability of moving lower.

Litigation threats and regulatory scrutiny cloud operational outlook

Securities class action lawsuits have been filed against Hims & Hers, with multiple law firms, including Pomerantz LLP, Glancy Prongay Wolke & Rotter LLP, and Kahn Swick & Foti, LLC, alleging failures to disclose consumer data sharing, premature prescription charges, and enrollment practices that may contravene federal law. These legal actions, as reported by Financialcontent, subject the company to heightened regulatory scrutiny and introduce the possibility of additional financial liabilities, potentially increasing uncertainty around operations and cash flows. The ongoing litigation risk remains a key factor for market participants assessing the near-term outlook for HIMS.

Bearish momentum as key resistances cap recovery attempts

On the hourly timeframe, HIMS is trading below both the MA-20 and MA-50, while remaining above the daily MA-200. Immediate resistance lies at the Ichimoku Kijun level of $28.89. Among momentum indicators, MACD indicates a Sell, ADX is Neutral, and both RSI and CCI also register Sell signals. Stochastic RSI is Neutral, with no extreme oversold readings, while Bull/Bear Power and the Awesome Oscillator are consistent with ongoing seller dominance and broad intraday weakness.

Downside scenarios favored as volatility compresses trading range

Short-term expectations center on HIMS ranging between $27.14 and $30.26, with typical volatility reflecting recent price action. The probability of a downward scenario is higher, at 79%, versus a 21% chance of a near-term rebound. Price action is likely to remain constrained within this band unless a move above immediate resistance near $28.89 triggers bullish momentum, or a break below $27.14 signals further decline.

Anton Kharitonov, expert at Traders Union, views the current setup for Hims & Hers as fragile. He notes that technical signals remain bearish and litigation risk compounds investor caution. Legal headlines are likely to limit upside until there is more clarity on regulatory exposure. "For now, I see defensive positioning as prudent, unless price recovers above resistance and legal overhang fades."

Earlier, analysts noted that Hims & Hers was facing persistent downside momentum and elevated risk amid technical weakness and increased regulatory scrutiny. The emergence of multiple securities class action lawsuits now strengthens the case for ongoing caution, with sustained price pressure likely unless the stock decisively reclaims resistance at $28.89.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.